Kyntra Bio Inc (KYNB) vs NewcelX Ltd. (NCEL)
- Kyntra Bio Inc KYNB 3.44 −4.18%
- NewcelX Ltd. NCEL 2.61 −2.97%
Kyntra Bio Inc and NewcelX Ltd. are both Biotechnology companies. Kyntra Bio Inc and NewcelX Ltd. are of similar size ($14.5M and $14.5M). NewcelX Ltd. has negative trailing earnings, so its P/E is not meaningful; Kyntra Bio Inc trades at 0.1×. Kyntra Bio Inc has the higher net margin (3,967.8% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Kyntra Bio Inc leads on 7 and NewcelX Ltd. on 4.
Valuation
Profitability
| Metric | KYNB | NCEL | Biotechnology median |
|---|---|---|---|
| Gross margin | 6.28% | 0.00% | 67.24% |
| Operating margin | (1,089.78%) | — | 0.00% |
| Net margin | 3,967.77% | 0.00% | 0.00% |
| Free cash flow margin | (824.19%) | 0.00% | 0.00% |
| Return on equity | (157.83%) | 0.00% | (50.28%) |
| Return on assets | 131.26% | 0.00% | (45.89%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack